MYCOPLASMA AND PRRSV VACCINE Russian patent published in 2011 - IPC A61K39/02 

FIELD: medicine, veterinary science.

SUBSTANCE: group of inventions concerns veterinary medicine. An immunogenic dose of the immunogenic material Mycoplasma hyopneumoniae and an immunogenic dose of live attenuated PRRS virus are used for producing a vaccine for combined introduction of the Mycoplasma hyopneumoniae vaccine and the PRRSV vaccine to Mycoplasma hyopneumoniae primed pigs. The immunogenic material Mycoplasma hyopneumoniae and live attenuated PRRS virus either can be, or are either in a common container, or in separate containers, and either mixed before introduction, or introduced consistently within no more than 24 hours. The method of pigs' vaccination implies the stages of primary vaccination (priming) with the Mycoplasma hyopneumoniae vaccine followed with combined vaccination with the immunogenic material Mycoplasma hyopneumoniae and live attenuated PRRS virus with the components Mycoplasma hyopneumoniae and PRRS being introduced consistently within no more than 24 hours.

EFFECT: group of inventions allows higher efficacy of mycoplasmosis and PRRSV vaccination in pigs.

6 cl, 2 ex